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There has been a dramatic increase in the use of percutaneous 
transluminal coronary angioplasty since its introduction in 
1977 by Andreas Gruentzig. More than 430,000 procedures 
were performed in 1994. Although coronary angioplasty once 
was directed at single-vessel lesions that were proximal, dis- 
crete, noncalcified and nonoccluded, technologic advances and 
new methods now allow it to be used for much more challeng- 
ing lesions. Its growing use and expanding indications make it 
one of the most important recent advances for the care of 
patients with coronary artery disease. 
Today, one of the factors limiting its more widespread use 
is cost. Coronary angioplasty is approximately one-third to 
one-half the cost of bypass surgery, yet it remains an expensive 
intervention, with an average cost of more than $5,000 (1) and 
an average charge of about $15,000 (2). The total charge for 
coronary angiophxsty was estimated to be more than $6 billion 
in 1994 (2). This amount is large enough to atTect he total cost 
of health care and is one reason that we need to develop ways 
of performing coronary angioplasty less expensively. 
We should expect that less expensive ways of performing 
the pmcedure can be. developed. The cost of coronary angio- 
plasty varies widely. The patient’s clinicaI presentation and 
other patient characteristics, such as coexistent comorbidities, 
account for almost half of the observed variance, with the 
remainder mainly attributable to procedural variables and 
delays (3). One strategy for reducing the cost of coronary 
angioplasty is to identify which procedural variables lead to low 
cost ways of performing the procedure and then to disseminate 
this information, in the expectation that widespread use of the 
less costly techniques will follow. 
In this issue of the Journal, Mak et al. (4) report on a study 
that measured the effect of catheter reuse on the overall cost of 
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coronary angioplasty, which is one technique that has been 
proposed to lower cost. The reuse of medical equipment is not 
a new idea, and in other fields of medicine, such as nephrology 
and anesthesiology, equipment marketed for single use is 
commonly reused. In the field of cardiology, ablation catheters 
and pacemakers are often reused. A prospective study of 
ablation catheter reuse in the United States (5) showed a 
significant saving of $381 per procedure with catheter reuse 
mainly from a 400% decrease in the cost of catheters. Core- 
nary angioplasty catheters themselves are reused routinely 
outside this country. The Canadian Council for Health Tech- 
nologies has suggested that reuse of coronary angtoplasty 
catheters can save $750 after three uses, and 39% of Canadian 
centers performing cardiac catheterization report reusing 
these catheters (6). Even in the United States, one survey 
found that 31% of hospitals reused coronary angioplasty 
catheters, making them the second most reused item after 
hemodialyzers (7). 
Recently, Plante et al. (8) compared the rates of angio- 
graphic success and the rates of adverse events for one strategy 
that reused coronary angioplasty catheters and another strat- 
egy that used the catheters only once. They studied one center 
in Quebec that reused coronary angioplasty catheters and 
another center in Toronto that did not reuse these catheters. 
Plante et al. reported that when the reuse center was compared 
with the single-use center, more catheters were used per lesion, 
there was less success crossing the lesion, procedure times were 
longer, and there was an increased volume of contrast medium 
needed per procedure. There also were more adverse clinical 
events at the reuse center, particularly in patients with unstable 
angina. 
In the study reported in this issue of the Journal, Mak et al. 
(4) combined these outcomes with costs from the Cleveland 
Clinic and then used theoretic models to compare the cost- 
effectiveness of the reuse s:rategy with that of the single-use 
strategy. They estimated that the median cost to treat a lesion 
with the single-use strategy was $8,800. In the reuse strategy, 
much of the cost saved from reusing catheters was lost treating 
complications. The overall cost of the reuse strategy thus 
depended primarhy on the cost of catheters and the rate of 
urgent revascularization after catheter use. There was a poten- 
tial saving of $480 with the reuse strategy in the best scenario, 
but there also was a potential increased cost of $1,075 in the 
worst scenario. There was little difference in cost between the 
two strategies in the most likely scenario. 
The article by Mali et al. (4) addresses an important issue in 
cardiology. The authors’ choice of a modeling technique was 
appropriate. Modeling techniques are powerful tools for esti- 
mating the trade-off between cost and quality and thus for 
determining whether we are getting value for money spent. 
Modeling techniques have proved useful in many other medi- 
cal decisions (9). Modeling techniques are especiahy useful when 
morepowe&dresearchdesignssuchasra&&xd,controhed 
trials and prospective cohort studies are not feasible, for 
example, when such trials ar- too expensive or unethical or 
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when we must wait long periods for their results. In the field of 
cardiology, modeling techniques have been used to predict the 
development of coronary heart disease and to assess cardio- 
vascular risk. Outside cardiology, modeling techniques have 
been used to make important policy decisions. For example, 
few policy statements about vaccine use are made today 
without reference to the results of modeling studies. Also, 
many of the better clinical guidelines and critical pathways that 
are being developed are based in part on the results of 
modeling studies. 
Although the study by Mak et al. (4) used appropriate 
modeling techniques, their study was limited by its dependen= 
on results from the study by Plante et al. (8) which were input 
into the model. Because the study by Plante et al. used an 
observational design, the single-use center and the reuse 
center had different types of patients, the operators used 
different techniques for angioplasty, and the operators may 
have had different levels of experience. For example, more 
patients at the reuse center had unstable angina, and they 
received more heparin and nitroglycerin infusions. Also, oper- 
ators at the reuse center, but not the single-use center, used 
progressive di!a!ion of lesions. Therefore, it is possible, even 
likely, that the worse outcomes observed in the reuse center 
resulted from differences other than those from catheter reuse. 
This possibility has been strengthened by the recent publi- 
cation of other studies that do not find the same problems with 
catheter reuse. Another observational study from Israel 
(lO,ll), where coronary angioplasty catheters are reused rou- 
tinely, failed to tind a significant difference in outcomes or 
adverse events when catheter reuse was compared with single 
use. Preliminary results from a double-blind, prospective, 
randomized trial comparing new and reused catheters in 1,033 
procedures (12) found that both types of catheters had com- 
parable abilities to cross lesions with similar safety records and 
angiographic efficacy. 
Even if catheter reuse is not cost-effective for all patients, it 
might be cost-effective for subgroups of patients who can be 
identified before the procedure. This possibility was not exam- 
ined by Mak et al. (4). Patients with chronic stable angina 
constitute one of the larger subgroups of patients who undergo 
coronary angioplasty. In the study by Plante et al. (8). patients 
with chronic stable angina had a favorable outcome irrespec- 
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tive of the type of catheter used. Therefore, if Mak et al. had 
modeled patients with chronic stable angina separately from 
other patients, they would not have found any additional cost 
from increased complications. Thus, a reuse strategy probably 
would have been cost-effective in patients with chronic stable 
angina. 
These considerations raise important, unanswered ques- 
tions about the article by Mak et al. Because of these ques- 
tions, we believe that its conclusions should not be accepted 
unless they are confirmed by additional studies. We suspect, 
however, that additional studies will find that there is some 
financial benefit from the reuse of coronary angioplasty cath- 
eters, at least in patient subgroups. 
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